Business Description
IMV Inc
NAICS : 325410
SIC : 3741
ISIN : CA44974L1031
Description
IMV Inc is a clinical-stage biopharmaceutical company developing a novel class of cancer vaccines based on DPX, its immune-educating technology platform. DPX is designed to inform a specific, coordinated and persistent anti-tumor immune response, that could change the lives of patients with cancer. Its therapeutic candidate, maveropepimut-S (MVP-S), is a DPX-based cancer vaccine that delivers antigenic peptides from survivin, a well-recognized cancer antigen commonly overexpressed in cancers. The company has one reportable and geographic segment.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
9-Day RSI | 100 | |||||
14-Day RSI | 99.99 | |||||
6-1 Month Momentum % | 19900 | |||||
12-1 Month Momentum % | 1900 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-Forward-Revenue | 14.92 | |||||
FCF Yield % | -426200 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:IMVIF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IMV Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -4.55 | ||
| Beta | 103.1667 | ||
| 3-Year Sharpe Ratio | 0.62 | ||
| 3-Year Sortino Ratio | 66.09 | ||
| Volatility % | 19908.38 | ||
| 14-Day RSI | 99.99 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.002 | ||
| 12-1 Month Momentum % | 1900 | ||
| 52-Week Range ($) | 0.00001 - 0.002 | ||
| Shares Outstanding (Mil) | 11.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
IMV Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
IMV Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 90 days | ||
| Second quarter earnings results for 2026 | 2026-08-20 | In 5 days | ||
| First quarter earnings results for 2026 | 2026-08-17 | In 2 days | ||
| Annual report for 2025 | 2026-08-10 | 0.00 (+0.00%) | ||
| 0.1:1 Stock Split | 2022-12-13 | 2.19 (-7.65%) | ||
| 0.3125:1 Stock Split | 2018-05-10 | 53.40 (+4.31%) |
Show
Entries
IMV Inc Frequently Asked Questions
What is IMV Inc(IMVIF)'s stock price today?
The current price of IMVIF is $0.00. The 52 week high of IMVIF is $0.00 and 52 week low is $0.00.
When is next earnings date of IMV Inc(IMVIF)?
The next earnings date of IMV Inc(IMVIF) is 2026-08-17 Est..
Does IMV Inc(IMVIF) pay dividends? If so, how much?
IMV Inc(IMVIF) does not pay dividend.
Guru Commentaries on OTCPK:IMVIF
No articles.
Press Release
Articles on IMV Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers